Germ cell tumor screening: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
(screening)
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
Ovarian germ cell tumor:
'''Ovarian germ cell tumor:'''
According to the US preventive services task force, [[screening]] for [[ovarian cancer]] is not recommended in [[asymptomatic]] women.<ref name="GrossmanCurry2018">{{cite journal|last1=Grossman|first1=David C.|last2=Curry|first2=Susan J.|last3=Owens|first3=Douglas K.|last4=Barry|first4=Michael J.|last5=Davidson|first5=Karina W.|last6=Doubeni|first6=Chyke A.|last7=Epling|first7=John W.|last8=Kemper|first8=Alex R.|last9=Krist|first9=Alex H.|last10=Kurth|first10=Ann E.|last11=Landefeld|first11=C. Seth|last12=Mangione|first12=Carol M.|last13=Phipps|first13=Maureen G.|last14=Silverstein|first14=Michael|last15=Simon|first15=Melissa A.|last16=Tseng|first16=Chien-Wen|title=Screening for Ovarian Cancer|journal=JAMA|volume=319|issue=6|year=2018|pages=588|issn=0098-7484|doi=10.1001/jama.2017.21926}}</ref>


Testicular germ cell tumor:
* According to the US preventive services task force, [[screening]] for [[ovarian cancer]] is not recommended in [[asymptomatic]] women.<ref name="GrossmanCurry2018">{{cite journal|last1=Grossman|first1=David C.|last2=Curry|first2=Susan J.|last3=Owens|first3=Douglas K.|last4=Barry|first4=Michael J.|last5=Davidson|first5=Karina W.|last6=Doubeni|first6=Chyke A.|last7=Epling|first7=John W.|last8=Kemper|first8=Alex R.|last9=Krist|first9=Alex H.|last10=Kurth|first10=Ann E.|last11=Landefeld|first11=C. Seth|last12=Mangione|first12=Carol M.|last13=Phipps|first13=Maureen G.|last14=Silverstein|first14=Michael|last15=Simon|first15=Melissa A.|last16=Tseng|first16=Chien-Wen|title=Screening for Ovarian Cancer|journal=JAMA|volume=319|issue=6|year=2018|pages=588|issn=0098-7484|doi=10.1001/jama.2017.21926}}</ref>
According to the '''KIT'' [[Mutation|Mutations]] Are Common in [[Testicular]] Seminomas' study, [[Screening (medicine)|screening]] for seminoma by using the highly sensitive combination of denaturing [[High performance liquid chromatography|high performance liquid chromatography (HPLC)]] and direct [[sequencing]] observed:<ref name="pmid14695343">{{cite journal |vauthors=Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC |title=KIT mutations are common in testicular seminomas |journal=Am. J. Pathol. |volume=164 |issue=1 |pages=305–13 |date=January 2004 |pmid=14695343 |pmc=1602213 |doi=10.1016/S0002-9440(10)63120-3 |url=}}</ref>
 
*[[Mutation|Mutations]] of KIT [[exon]] 17
'''Testicular germ cell tumor:'''
*[[Mutation|Mutations]] of D816H  
 
*[[Mutation|Mutations]] of Y823D
* According to the '''KIT'' [[Mutation|Mutations]] Are Common in [[Testicular]] Seminomas' study, [[Screening (medicine)|screening]] for seminoma by using the highly sensitive combination of denaturing [[High performance liquid chromatography|high performance liquid chromatography (HPLC)]] and direct [[sequencing]] observed:<ref name="pmid14695343">{{cite journal |vauthors=Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC |title=KIT mutations are common in testicular seminomas |journal=Am. J. Pathol. |volume=164 |issue=1 |pages=305–13 |date=January 2004 |pmid=14695343 |pmc=1602213 |doi=10.1016/S0002-9440(10)63120-3 |url=}}</ref>
**[[Mutation|Mutations]] of KIT [[exon]] 17
**[[Mutation|Mutations]] of D816H
**[[Mutation|Mutations]] of Y823D
 
'''Germinoma:'''
 
*According to the United States Preventive Services Task Force, [[Screening (medicine)|screening]] for intracranial germ cell tumor (germinoma) is not recommended among the general population.<ref name="screening">http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=germinoma Accessed on January 26, 2016.</ref>
 
 
 
 
 
 
==References==
{{reflist|2}}

Latest revision as of 19:59, 21 August 2019

Ovarian germ cell tumor:

Testicular germ cell tumor:

Germinoma:

  • According to the United States Preventive Services Task Force, screening for intracranial germ cell tumor (germinoma) is not recommended among the general population.[3]




References

  1. ↑ Grossman, David C.; Curry, Susan J.; Owens, Douglas K.; Barry, Michael J.; Davidson, Karina W.; Doubeni, Chyke A.; Epling, John W.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phipps, Maureen G.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen (2018). "Screening for Ovarian Cancer". JAMA. 319 (6): 588. doi:10.1001/jama.2017.21926. ISSN 0098-7484.
  2. ↑ Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC (January 2004). "KIT mutations are common in testicular seminomas". Am. J. Pathol. 164 (1): 305–13. doi:10.1016/S0002-9440(10)63120-3. PMC 1602213. PMID 14695343.
  3. ↑ http://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=germinoma Accessed on January 26, 2016.
Retrieved from "https://www.wikidoc.org/index.php?title=Germ_cell_tumor_screening&oldid=1580303"